TLON..$1.64 The ONXX approval of Carfolzomib was huge IMO. Their approval was one week early. Those were the only two drugs (Carfolzomib & Marqibo) all year with Accelerated Approval (standard review) in 2012. Carfilzomib was approved on July 20th. A few others had priority review. Both had positive ADCOM Mtngs. The company is in label negotiations with the FDA. An analyst, gregory Wade, with Wedbush Securities thinks that is a very positive thing. http://bloom.bg/IDzv8m